LifePoint Health (NASDAQ:LPNT) was upgraded by equities research analysts at UBS from a “market perform” rating to an “outperform” rating in a report issued on Thursday, March 15th, The Fly reports.
A number of other brokerages also recently issued reports on LPNT. Goldman Sachs began coverage on shares of LifePoint Health in a report on Wednesday, January 3rd. They issued a “sell” rating and a $45.00 price target for the company. ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Cantor Fitzgerald reaffirmed a “hold” rating and set a $50.00 price target on shares of LifePoint Health in a research note on Friday, February 23rd. Wells Fargo initiated coverage on shares of LifePoint Health in a research note on Tuesday, January 30th. They set a “market perform” rating and a $52.00 price target on the stock. Finally, BidaskClub upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and seven have given a buy rating to the company’s stock. LifePoint Health has an average rating of “Hold” and an average target price of $55.18.
LPNT stock traded down $0.65 during midday trading on Thursday, reaching $49.00. 199,595 shares of the company’s stock traded hands, compared to its average volume of 584,305. The company has a quick ratio of 1.49, a current ratio of 1.70 and a debt-to-equity ratio of 1.26. LifePoint Health has a 12 month low of $41.45 and a 12 month high of $67.95. The firm has a market cap of $1,958.63, a PE ratio of 20.18, a PEG ratio of 1.52 and a beta of 0.57.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, February 23rd. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.04). The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.58 billion. LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The firm’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.07 EPS. sell-side analysts predict that LifePoint Health will post 4.27 earnings per share for the current year.
In other news, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the transaction, the insider now owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman William F. Carpenter III purchased 21,368 shares of LifePoint Health stock in a transaction dated Wednesday, February 28th. The shares were purchased at an average cost of $46.80 per share, with a total value of $1,000,022.40. Following the acquisition, the chairman now owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. Insiders own 8.76% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Millennium Management LLC increased its stake in LifePoint Health by 583.3% in the 4th quarter. Millennium Management LLC now owns 947,579 shares of the company’s stock worth $47,189,000 after purchasing an additional 808,906 shares in the last quarter. American Century Companies Inc. grew its stake in LifePoint Health by 16.3% during the 4th quarter. American Century Companies Inc. now owns 4,220,590 shares of the company’s stock valued at $210,185,000 after acquiring an additional 590,103 shares in the last quarter. Boston Partners grew its stake in LifePoint Health by 50.8% during the 4th quarter. Boston Partners now owns 874,690 shares of the company’s stock valued at $43,559,000 after acquiring an additional 294,480 shares in the last quarter. Bank of New York Mellon Corp grew its stake in LifePoint Health by 28.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock valued at $46,044,000 after acquiring an additional 177,329 shares in the last quarter. Finally, First Trust Advisors LP grew its stake in LifePoint Health by 33.4% during the 4th quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock valued at $20,630,000 after acquiring an additional 103,680 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: This report was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://ledgergazette.com/2018/03/23/lifepoint-health-lpnt-upgraded-by-ubs-group-to-outperform.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.